Correlational validity; Pearson correlations at baseline and of all visits
Baseline/ All visits (grey background) | |||||
DAPSA | DAPSA28 | DAS28CRP | SDAI | CDAI | |
DAPSA | 1 | 0.93* (n=1033) | 0.87* (n=1033) | 0.92* (n=947) | 0.92* (n=947) |
DAPSA28 | 0.94* (n=6421) | 1 | 0.93* (n=2399) | 0.99* (n=2148) | 0.99* (n=2148) |
DAS28CRP | 0.89* (n=6421) | 0.94* (n=20 406) | 1 | 0.94* (n=2189) | 0.92* (n=2189) |
SDAI | 0.94* (n=5888) | 0.99* (n=18 565) | 0.94* (n=18 819) | 1 | 0.99* (n=2189) |
CDAI | 0.94* (n=5888) | 0.99* (n=18 565) | 0.92* (n=18 819) | 0.99* (n=18 819) | 1 |
*P<0.001 (p found by GEE when multiple registrations per patient).
CDAI, clinical disease activity index;CRP, C reactive protein;DAS28CRP, 28-joint disease activity score with CRP;GEE, generalised estimating equation;SDAI, simplified disease activity index.